MANIPULATION OF EPITHELIAL-TO-MESENCHYMAL TRANSITION REVEALS METASTATIC BREAST CANCERS SUPPORT IMMUNE SUPPRESSION VIA HEME METABOLISM

被引:1
|
作者
Williams, Michelle [1 ]
Hafeez, Sabrina [1 ]
Christenson, Jessica [1 ]
Spoelstra, Nicole [1 ]
Slansky, Jill [1 ]
Richer, Jennifer [1 ]
机构
[1] Univ Colorado, Anschutz Med Campus, Aurora, CO USA
关键词
D O I
10.1136/jitc-2021-SITC2021.890
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
890
引用
收藏
页码:A933 / A933
页数:1
相关论文
共 50 条
  • [21] TNF-alpha mediates immune editing of breast cancers by inducing epithelial to mesenchymal transition
    Knutson, KL
    Prosperi, C
    Bronson, J
    JOURNAL OF IMMUNOTHERAPY, 2005, 28 (06) : 645 - 646
  • [22] PROM2 overexpression induces metastatic potential through epithelial-to-mesenchymal transition and ferroptosis resistance in human cancers
    Paris, Justine
    Wilhelm, Claire
    Lebbe, Celeste
    Elmallah, Mohammed
    Pamoukdjian, Frederic
    Heraud, Audrey
    Gapihan, Guillaume
    Van De Walle, Aurore
    Tran, Van Nhan
    Hamdan, Diaddin
    Allayous, Clara
    Battistella, Maxime
    Van Glabeke, Emmanuel
    Lim, Kah Wai
    Leboeuf, Christophe
    Roger, Sebastien
    Falgarone, Geraldine
    Phan, Anh Tuan
    Bousquet, Guilhem
    CLINICAL AND TRANSLATIONAL MEDICINE, 2024, 14 (03):
  • [23] In patients with metastatic breast cancer the identification of circulating tumor cells in epithelial-to-mesenchymal transition is associated with a poor prognosis
    Michela Bulfoni
    Lorenzo Gerratana
    Fabio Del Ben
    Stefania Marzinotto
    Marisa Sorrentino
    Matteo Turetta
    Giacinto Scoles
    Barbara Toffoletto
    Miriam Isola
    Carlo Alberto Beltrami
    Carla Di Loreto
    Antonio Paolo Beltrami
    Fabio Puglisi
    Daniela Cesselli
    Breast Cancer Research, 18
  • [24] In patients with metastatic breast cancer the identification of circulating tumor cells in epithelial-to-mesenchymal transition is associated with a poor prognosis
    Bulfoni, Michela
    Gerratana, Lorenzo
    Del Ben, Fabio
    Marzinotto, Stefania
    Sorrentino, Marisa
    Turetta, Matteo
    Scoles, Giacinto
    Toffoletto, Barbara
    Isola, Miriam
    Beltrami, Carlo Alberto
    Di Loreto, Carla
    Beltrami, Antonio Paolo
    Puglisi, Fabio
    Cesselli, Daniela
    BREAST CANCER RESEARCH, 2016, 18
  • [25] The role of DYNLT3 in breast cancer proliferation, migration, and invasion via epithelial-to-mesenchymal transition
    Wang, Han
    Chen, Xin
    Jin, Yanshan
    Liu, Tingxian
    Song, Yizuo
    Zhu, Xuejie
    Zhu, Xueqiong
    CANCER MEDICINE, 2023, 12 (14): : 15289 - 15303
  • [26] Asiatic acid attenuates malignancy of human metastatic ovarian cancer cells via inhibition of epithelial-to-mesenchymal transition
    Wang, Xiufen
    Sun, Jie
    Liu, Feifei
    Bian, Yinghui
    Miao, Lili
    Wang, Xinbo
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2017, 16 (06) : 1223 - 1229
  • [27] BREAST TUMOR CELL HEME METABOLISM ALTERS MACROPHAGE IMMUNE SUPPRESSION AND FUNCTION TO SUPPORT LUNG METASTASIS
    Williams, Michelle
    Hafeez, Sabrina
    Christenson, Jessica
    Spoelstra, Nicole
    O'Neill, Kathleen
    Kuo, Li-Wei
    Crump, Lyndsey
    Slansky, Jill
    Richer, Jennifer
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1479 - A1479
  • [28] Circulating Tumor Cells with Stemness and Epithelial-to-Mesenchymal Transition Features Are Chemoresistant and Predictive of Poor Outcome in Metastatic Breast Cancer
    Papadaki, Maria A.
    Stoupis, Giannis
    Theodoropoulos, Panayiotis A.
    Mavroudis, Dimitris
    Georgoulias, Vassilis
    Agelaki, Sofia
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (02) : 437 - 447
  • [29] Antrodin C Inhibits Epithelial-to-Mesenchymal Transition and Metastasis of Breast Cancer Cells via Suppression of Smad2/3 and β-Catenin Signaling Pathways
    Kumar, K. J. Senthil
    Vani, M. Gokila
    Chueh, Pin-Ju
    Mau, Jeng-Leun
    Wang, Sheng-Yang
    PLOS ONE, 2015, 10 (02):
  • [30] Azithromycin ameliorates OVA-induced airway remodeling in Balb/c mice via suppression of epithelial-to-mesenchymal transition
    Pu, Yue
    Liu, Yuanqi
    Liao, Shiping
    Miao, Shikun
    Zhou, Liming
    Wan, Lihong
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2018, 58 : 87 - 93